Segn las guas de la Asociacin Americana de Diabetes (ADA), los agonistas del GLP-1 como la semaglutida son opciones de tratamiento preferidas para pacientes con diabetes tipo 2 que requieren terapia adicional ms all de la metformina, especialmente cuando existe enfermedad cardiovascular establecida o alto riesgo cardiovascular
While brand-name Ozempic carries FDA approval, compounded versions are not FDA-approved but are legally produced under pharmaceutical-grade oversight
The treatment is tied to the condition
Its important to note that compounded medications do not go through the same FDA approval process or review for safety, quality, or effectiveness
Gaudiano et al., 2024
Phase II pathways attach glutathione, glucuronic acid, sulfate, glycine, taurine, acetyl groups or methyl groups